The trademark application ARC-SparX was filed by Arcellx, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on June 22, 2022, and still open for oppositions.
The application was filed in English (French was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Biological preparations for the treatment of cancer using genetically engineered cells
Pharmaceutical preparations for targeting tissues based on select tissue markers and ligands
Pharmaceutical preparations for the purpose of binding ligands using receptors
Pharmaceutical preparations for immunotherapy using genetically engineered cells.